Katie Thurston reveals her HER2-negative breast cancer is treated with hormone therapy instead of chemo, detailing her custom treatment plan.

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Thousands with advanced breast cancer could live long lives thanks to a new drug approved on the NHS . Capivasertib, retailed ...

Researchers have found new compounds that could be used to treat a common breast cancer that can be resistant to hormone ...

Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...

This is the opposite of most breast ... of treatment,” her caption continued. “This is a custom plan based on being [/] having HER2-negative, Luminal B, hormone-positive breast cancer.

The Coordinator of the National Cancer Control Programme, Ministry of Health and Social Welfare, Dr Uche Nwokwu, has said ...

Even after the removal of breast tissue, it is possible that the cancer may recur in the chest wall or the area where the ...

The incidence of interval breast cancer has increased over a 30-year period while the proportion has remained steady.

The National Institute for Health and Care Excellence (NICE) has approved the use of the tablet capivasertib, in combination ...